Axxam S.p.A Axxam S.p.A

Axxam S.p.A. is a privately owned contract research and discovery company located at Openzone Science Park, Bresso (Milan), Italy, with chemistry laboratories located in Naples (Italy) and business de ... velopment offices in Europe, US and Japan. Since its inception in 2001, as a spin-off from the Bayer Group, Axxam has supported the discovery programs of its clients by providing excellent quality discovery services carried out by highly engaged scientists, complemented by pharmaceutical industry experience from both management, as well as, the scientific teams. Our capabilities and expertise include: • Molecular biology (cloning, gene expression analysis, protein expression, genomic engineering) • Assay development and reagent provision (cellular and biochemical systems) • Compound management • Fully automated High Throughput Screening (various readouts including radiometric formats) • Fully automated High Content Screening and imaging • Hit characterization & profiling • Access to AXXDIV4.0 compound collection (around 325,000 compounds) • Cardiac safety and liability profiling • Electrophysiology These capabilities paired with our discovery mentality have allowed us to successfully execute: • Hit identification projects • Hit-to-lead projects • Lead optimization programs We are guided by a truly collaborative mentality, based on transparent processes and open communication. We provide resources, expertise in a broad range of target classes, know-how, but also a problem-solving attitude and passion for our work. Each customer is equally important to us and this can be ascertained by the fact that more than 70% of our business are made up of repeated contracts. Axxam’s customer base is distributed around the globe and comprise companies active in Pharmaceutical, Crop protection, Animal health, Cosmetics and Nutrition. Axxam is also engaged in developing novel, innovative therapies for diseases with high unmet medical needs. Read more

• Pharmaceuticals